Tamerah N Hunt1, Michael S Ferrara. 1. The Ohio State University Sports Medicine Center, Columbus, OH 43221, USA. tamerah.hunt@osumc.edu
Abstract
CONTEXT: Clinicians have questioned the need to obtain annual baseline neuropsychological tests in high school athletes. If no difference among academic grades exists, annual baseline testing may not be necessary. OBJECTIVE: To examine differences at baseline testing on pencil-and-paper neuropsychological tests among grade levels in high school athletes. DESIGN: Cross-sectional, between-groups design. SETTING: Schools participating in a Georgia high school athletics association. PATIENTS OR OTHER PARTICIPANTS: High school football players (n = 198) in the 9th through 12th grades, with a mean age of 15.78 +/- 1.16 years. MAIN OUTCOME MEASURE(S): Participants were divided into 4 groups by grade and were administered a symptom checklist and brief neuropsychological test battery. Grade level served as the independent variable. Symptom and individual test scores within the neuropsychological test battery served as dependent variables. RESULTS: Differences were noted among grades on the Trail Making Test A (F(3,194) = 3.23, P = .024, eta(2) = 0.048), Trail Making Test B (F(3,194) = 3.93, P = .009, eta(2) = 0.057), Symbol Digit Modalities Test (F(3,194) = 4.38, P = .005, eta(2) = 0.064), dominant tap (F(3,194) = 3.14, P = .026, eta(2) = 0.046), and nondominant tap (F(3,194) = 4.902, P = .003, eta(2) = 0.070). Using the Bonferroni correction (P <or= .00625), we found differences between the 9th grade and 11th and 12th grades. CONCLUSIONS: Baseline neuropsychological test scores in high school athletes improved as a function of age, with differences between the 9th grade and 11th and 12th grades. Because the differences were driven by 9th-grade test scores, baseline testing should be completed, at minimum, upon entrance into 9th and 10th grades; however, annual testing is still recommended until additional research is conducted.
CONTEXT: Clinicians have questioned the need to obtain annual baseline neuropsychological tests in high school athletes. If no difference among academic grades exists, annual baseline testing may not be necessary. OBJECTIVE: To examine differences at baseline testing on pencil-and-paper neuropsychological tests among grade levels in high school athletes. DESIGN: Cross-sectional, between-groups design. SETTING: Schools participating in a Georgia high school athletics association. PATIENTS OR OTHER PARTICIPANTS: High school football players (n = 198) in the 9th through 12th grades, with a mean age of 15.78 +/- 1.16 years. MAIN OUTCOME MEASURE(S): Participants were divided into 4 groups by grade and were administered a symptom checklist and brief neuropsychological test battery. Grade level served as the independent variable. Symptom and individual test scores within the neuropsychological test battery served as dependent variables. RESULTS: Differences were noted among grades on the Trail Making Test A (F(3,194) = 3.23, P = .024, eta(2) = 0.048), Trail Making Test B (F(3,194) = 3.93, P = .009, eta(2) = 0.057), Symbol Digit Modalities Test (F(3,194) = 4.38, P = .005, eta(2) = 0.064), dominant tap (F(3,194) = 3.14, P = .026, eta(2) = 0.046), and nondominant tap (F(3,194) = 4.902, P = .003, eta(2) = 0.070). Using the Bonferroni correction (P <or= .00625), we found differences between the 9th grade and 11th and 12th grades. CONCLUSIONS: Baseline neuropsychological test scores in high school athletes improved as a function of age, with differences between the 9th grade and 11th and 12th grades. Because the differences were driven by 9th-grade test scores, baseline testing should be completed, at minimum, upon entrance into 9th and 10th grades; however, annual testing is still recommended until additional research is conducted.
Authors: Kevin M Guskiewicz; Scott L Bruce; Robert C Cantu; Michael S Ferrara; James P Kelly; Michael McCrea; Margot Putukian; Tamara C Valovich McLeod Journal: J Athl Train Date: 2004-09 Impact factor: 2.860
Authors: V A Anderson; S A Morse; G Klug; C Catroppa; F Haritou; J Rosenfeld; L Pentland Journal: J Int Neuropsychol Soc Date: 1997-11 Impact factor: 2.892
Authors: Michael McCrea; Kevin M Guskiewicz; Stephen W Marshall; William Barr; Christopher Randolph; Robert C Cantu; James A Onate; Jingzhen Yang; James P Kelly Journal: JAMA Date: 2003-11-19 Impact factor: 56.272
Authors: William T Tsushima; Andrea M Siu; Annina M Pearce; Guangxiang Zhang; Ross S Oshiro Journal: Arch Clin Neuropsychol Date: 2015-11-15 Impact factor: 2.813
Authors: Steven P Broglio; Jaroslaw Harezlak; Barry Katz; Shi Zhao; Thomas McAllister; Michael McCrea Journal: Sports Med Date: 2019-12 Impact factor: 11.136
Authors: Steven P Broglio; Robert C Cantu; Gerard A Gioia; Kevin M Guskiewicz; Jeffrey Kutcher; Michael Palm; Tamara C Valovich McLeod Journal: J Athl Train Date: 2014-03-07 Impact factor: 2.860
Authors: Johna K Register-Mihalik; Daniel L Kontos; Kevin M Guskiewicz; Jason P Mihalik; Robert Conder; Edgar W Shields Journal: J Athl Train Date: 2012 May-Jun Impact factor: 2.860